21:10 , May 9, 2019 |  BioCentury  |  Finance

Cortexyme’s first-day pop leads IPO quartet amid choppy market

Despite unsettled market conditions, a foursome of biotechs priced their IPOs within their proposed ranges ahead of first-day trading Thursday and helped push the year-to-date tally of money raised in public market debuts well ahead...
23:32 , Apr 30, 2019 |  BC Extra  |  Financial News

April 30 Financial Quick Takes: Mustang, Tot Biopharm, Axcella and more

Mustang raises $27.5M after gene therapy data Mustang Bio Inc. (NASDAQ:MBIO) raised $27.5 million in a follow-on underwritten by Cantor Fitzgerald, Oppenheimer, H.C. Wainwright and Roth Capital. The offering comes on the heels of positive...
22:01 , Apr 12, 2019 |  BC Extra  |  Financial News

Flagship-backed Axcella seeking NASDAQ IPO

With its lead program headed for its first post-IND clinical study, Axcella proposed to raise up to $86.3 million in an IPO on NASDAQ. Axcella Health Inc. (Cambridge, Mass.) is developing a pipeline of endogenous...
23:28 , Mar 27, 2019 |  BC Extra  |  Financial News

Elicio raises $30M to target cancer vaccines to the lymph nodes

Elicio launched Wednesday with $30 million in funding and an immunotherapy strategy aimed at getting cancer vaccines into the lymph nodes, a location that orchestrates immune responses but has been hard to target directly. Elicio...
22:48 , Mar 27, 2019 |  BC Extra  |  Company News

Management tracks: Epic, Axcella, KalVista

Lloyd Sanders will succeed Murali Prahalad as president and CEO of cancer diagnostic company Epic Sciences Inc. (San Diego, Calif.). Sanders was president of the oncology segment of molecular diagnostics company Myriad Genetics Inc. (NASDAQ:MYGN)....
23:26 , Nov 13, 2018 |  BC Extra  |  Company News

Management tracks: Anchiano, ContraFect

Cancer company Anchiano Therapeutics Inc. (Tel Aviv:ANCN) appointed Stephen Hoffman chairman. He is CEO of Aerpio Pharmaceuticals Inc. (OTCQB:ARPO). Anchiano also named Robert Connelly a director. He was a venture partner at Flagship Pioneering and...
20:48 , Oct 23, 2018 |  BC Extra  |  Company News

Management tracks: Celgene, Seres, AC Immune

Celgene Corp. (NASDAQ:CELG) hired Alise Reicin as president of global clinical development, a newly created position. She was SVP and head of global clinical development in R&D at the EMD Serono business of Merck KGaA...
22:29 , May 31, 2018 |  BC Extra  |  Company News

Management tracks: Axcella, Arcturus, Orexo

Metabolic dysregulation company Axcella Health Inc. (Cambridge, Mass.) hired William Hinshaw as president and CEO. He was EVP and head of U.S. oncology at Novartis AG (NYSE:NVS; SIX:NOVN). RNA therapeutics company Arcturus Therapeutics Ltd. (NASDAQ:ARCT)...
21:33 , Mar 13, 2018 |  BC Extra  |  Company News

Management tracks: Ipsen, Illumina

Ipsen Group (Euronext:IPN; Pink:IPSEY) hired Ivana Magovcevic-Liebisch as EVP and CBO. She was EVP and chief strategy and corporate development officer at Axcella Health Inc. (Cambridge, Mass.). Genomics company Illumina Inc. (NASDAQ:ILMN) hired Phil Febbo...
23:54 , Jan 4, 2018 |  BC Extra  |  Company News

Management tracks: Acceleron, Selecta

Acceleron Pharma Inc. (NASDAQ:XLRN) said EVP and CMO Matthew Sherman will retire after the company reports top-line data mid-year from the Phase III MEDALIST and BELIEVE trials of luspatercept (ACE-536) to treat lower-risk myelodysplastic syndromes...